The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback